title: [Effectiveness of immunomodulating therapy of pulmonary tuberculosis with cycloferon].
abstract: Cycloferon was used to treat newly diagnosed, recurrent and long-standing pulmonary TB. The dose of 7,5 g combined with antibacterial therapy caused no complications. The effectiveness of this therapy based on the generally-accepted criteria was significantly higher than standard treatment but varied depending on the character of pathological process. It is recommended to use cycloferon in the intense phase of the basal treatment.
authors.forename: V M
authors.initials: VM
authors.lastname: Kolomiets
authors.forename: N V
authors.initials: NV
authors.lastname: Rubleva
mesh_terms: D000166:Acridines / Q000008:administration & dosage / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D056747:Immunomodulation; D007369:Interferon Inducers / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000166:Acridines; D000900:Anti-Bacterial Agents; D007369:Interferon Inducers; C026430:10-carboxymethyl-9-acridanone